- Email: [email protected]
1194. Development and Characterization of Oncolytic HSV-1 Vectors Expressing Prodrug-Activating Enzymes
"? $,9 6& ;9H - B&H±5/
59H -±;&/ $,9 ? "? ( @ 3
' 59H
899H
$&& $&5 $,9"
3
? %
3
!@ $,9
3
B 7 3
@2. % $,9 ? 1
-!! / $,9 $*' "8 >?8
,9 =9H
3
D", 6: >?8 -#?/ &59±5: =98±886
$,9 # "D @
1193. Receptor-T argeted AA VV ector-Mediated Receptor-Targeted AAV Vector-Mediated Expression of HSV-TK Confers Selective Cytotoxicity to Human Ovarian Adenocarcinoma Cells Wenfang Shi, Jeffrey S. Bartlett. ) ′ $ 1
" "
=9 #
) E
"
0
"
-''./ "
G 3 "8 -C(. / ''.
"
''. C(. #. %
''. ,5= C
''.,
" 6"@ $ - ./
# ("
?'( ''. 6"@ $ -''."'&::6"@ $/ . 3
0
3 * '&::6"@ $ ''."C(. % .
3 C(! ''.", " ''."C(. % .
"
''. 3 ''. 3
1194. Development and Characterization of Oncolytic HSV -1 V ectors Expressing Prodrug-Activating Enzymes HSV-1 Vectors Edyta Tyminski,1 Kinya Terada,1 Mary K. Danks,2 Philip M. Potter,2 Yoshinaga Saeki,1 E. Antonio Chiocca.1 1 Molecular Neuro-Oncology Laboratories, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States; 2Department of Molecular Pharmacology, St. Jude Children’s Research Hospital, Memphis, TN, United States. @ " -/ 3 "8 -C(." 8/ - # C8 ,9;/ !B -
3/
!=6&- / " G ?
C 3 C(."8
0
G
C(."8 3
3 " G " "
0 " +!,28 % -!'/ 3 ->/ % ! "88
?
C(."8
3 "
2 "
3 C(."8"
"
0
C(."8
3 8/ +!,28 ,/ > =/ +!,28 >
-C S / " -?" ?@ "3!/
1 C(."8
1 C(."8 2' -C S "8/ 0 G " C(."8 "
1195. Cytotoxic Effect of HSV -TK/GCV Suicide Gene HSV-TK/GCV Therapy Can Be Enhanced with Polyamine Depletion Tiina Pasanen,1 Anne Karppinen,1 Leena Alhonen,1 Juhani Janne,1 Jarmo Wahlfors.1 1 Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute, University of Kuopio, Kuopio, Finland. C(." A%
3
C
0
,"
-$?#)/
"
C(." A% . 5D (
5D .
$?#) . - /
. ("
.
="6 $?#) 3
,& 7
C(." A% .
1196. Cytochrome P450 Gene-Directed Enzyme Prodrug Therapy (GDEPT) for Cancer David J. Waxman, Youssef Jounaidi, Pamela S. Schwartz, ChongSheng Chen, Jodi E. D. Hecht. 1 Department of Biology, Division of Cell and Molecular Biology, Boston University, Boston, MA, United States. (
G
S388
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
59H -±;&/ $,9 ? "? ( @ 3
' 59H
899H
$&& $&5 $,9"
3
? %
3
!@ $,9
3
B 7 3
@2. % $,9 ? 1
-!! / $,9 $*' "8 >?8
,9 =9H
3
D", 6: >?8 -#?/ &59±5: =98±886
$,9 # "D @
1193. Receptor-T argeted AA VV ector-Mediated Receptor-Targeted AAV Vector-Mediated Expression of HSV-TK Confers Selective Cytotoxicity to Human Ovarian Adenocarcinoma Cells Wenfang Shi, Jeffrey S. Bartlett. ) ′ $ 1
" "
=9 #
) E
"
0
"
-''./ "
G 3 "8 -C(. / ''.
"
''. C(. #. %
''. ,5= C
''.,
" 6"@ $ - ./
# ("
?'( ''. 6"@ $ -''."'&::6"@ $/ . 3
0
3 * '&::6"@ $ ''."C(. % .
3 C(! ''.", " ''."C(. % .
"
''. 3 ''. 3
1194. Development and Characterization of Oncolytic HSV -1 V ectors Expressing Prodrug-Activating Enzymes HSV-1 Vectors Edyta Tyminski,1 Kinya Terada,1 Mary K. Danks,2 Philip M. Potter,2 Yoshinaga Saeki,1 E. Antonio Chiocca.1 1 Molecular Neuro-Oncology Laboratories, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States; 2Department of Molecular Pharmacology, St. Jude Children’s Research Hospital, Memphis, TN, United States. @ " -/ 3 "8 -C(." 8/ - # C8 ,9;/ !B -
3/
!=6&- / " G ?
C 3 C(."8
0
G
C(."8 3
3 " G " "
0 " +!,28 % -!'/ 3 ->/ % ! "88
?
C(."8
3 "
2 "
3 C(."8"
"
0
C(."8
3 8/ +!,28 ,/ > =/ +!,28 >
-C S / " -?" ?@ "3!/
1 C(."8
1 C(."8 2' -C S "8/ 0 G " C(."8 "
1195. Cytotoxic Effect of HSV -TK/GCV Suicide Gene HSV-TK/GCV Therapy Can Be Enhanced with Polyamine Depletion Tiina Pasanen,1 Anne Karppinen,1 Leena Alhonen,1 Juhani Janne,1 Jarmo Wahlfors.1 1 Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute, University of Kuopio, Kuopio, Finland. C(." A%
3
C
0
,"
-$?#)/
"
C(." A% . 5D (
5D .
$?#) . - /
. ("
.
="6 $?#) 3
,& 7
C(." A% .
1196. Cytochrome P450 Gene-Directed Enzyme Prodrug Therapy (GDEPT) for Cancer David J. Waxman, Youssef Jounaidi, Pamela S. Schwartz, ChongSheng Chen, Jodi E. D. Hecht. 1 Department of Biology, Division of Cell and Molecular Biology, Boston University, Boston, MA, United States. (
G
S388
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy